Cheplapharm: Pharma Company Unify Processes with the CARA Life Sciences Platform

This is a thin landing page stating that Cheplapharm Arzneimittel GmbH, a German pharmaceutical company based in Greifswald, adopted the CARA Life Sciences Platform for data management starting in 2022, with 500 users. Beyond the user count and start date, the visible page gives no detail on the original challenge, implementation process, or quantified business outcomes -- it functions largely as promotional scaffolding rather than a full narrative case study.

Generis makes the CARA platform, the regulatory/quality/clinical content backbone used by major pharma companies, now with AI document-classification features built in.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.